Department of Health and Human Services, through National Institutes of Health, awarded Objective Biotechnology, Inc. of Minneapolis, MN $803,099 under the STTR program (Phase I), with work starting 2025-09-15 and running to 2027-08-31. It is one of 2 SBIR and STTR awards Objective Biotechnology, Inc. received in the last two years, $1,282,893 in all. Each figure links to the federal record.
The award
| Recipient | Objective Biotechnology, Inc. (Minneapolis, MN) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase I |
| Amount obligated | $803,099 |
| Period of performance starts | 2025-09-15 |
| Period of performance ends | 2027-08-31 |
| Award number | R41OD039877 (grant, CFDA 93.351) |
| Assistance listing | 93.351, Research Infrastructure Programs |
| Place of performance | Minneapolis, Hennepin County, MN |
| Signed | 2025-09-03 |
| Recipient registry id (UEI) | GN5KBQRNCBA9 |
Want the whole picture on Objective Biotechnology, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Objective Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Objective Biotechnology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
High performance miniaturized microscopes for through skull cortex-wide imaging in freely behaving mice - project summary the mammalian cerebral cortex plays a crucial role in learned and adaptive sensory-motor behaviors
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-08-20 | Continuation | 000 | $386,174 |
| 2025-09-03 | New | 000 | $416,925 |
High performance miniaturized microscopes for through skull cortex-wide imaging in freely behaving mice - project summary the mammalian cerebral cortex plays a crucial role in learned and adaptive sensory-motor behaviors, with its evolutionary expansion contributing to advanced cognitive abilities in humans and primates. While progress has been made in understanding regional cortical computations, the coordination of neural activity across the cortex for unified behavioral outputs remains poorly understood. The innovation described involves the development of the mini-mscope, a miniature imaging device capable of mesoscale dynamic measurements across the cortex in freely behaving mice. Weighing 3.8G, the mini-mscope has been distributed to several laboratories globally, demonstrating its efficacy in dorsal cortical activity imaging during various behaviors. Beta testing revealed two key issues: Limited behavior testing and a challenging implantation procedure. The proposed Phase I, small business technology transfer (STTR) project aims to address these concerns by engineering a mini-mscope with a highly sensitive imaging CMOS sensor, evaluating its performance in through-skull imaging, and comprehensively assessing its imaging capabilities across diverse behavioral contexts. Successful outcomes are expected to enhance the mini-mscope's commercial viability, facilitating wider a ...
From the federal award record.
Other SBIR and STTR awards to Objective Biotechnology, Inc.
| Starts | Agency | Program | Amount | Project |
|---|---|---|---|---|
| 2026-09-11 | Department of Health and Human Services | STTR Phase I | $479,794 | Bionic imaging platform (bip) for high performance functional imaging in freely navigating (record) |
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Objective Biotechnology, Inc.Look up Objective Biotechnology, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.